Soligenix to Present at World Vaccine Congress & Expo
PRINCETON N.J. April 16 2013 PRNewswire &160;Soligenix Inc. OTCQB SNGX Soligenix or the Company a clinical stage biopharmaceutical company focused on developing products for serious inflammatory...
View ArticleVitality Biopharma Advisor to Present Pediatric IBD Case Study at ICRS2017 in...
Dr. Natasha Ryz a Vitality research advisor will present a case study report on cannabinoid treatment for pediatric Crohn's disease LOS ANGELES CAMarketwired JunRead more...
View ArticleQueens Medical Associates Founder Dr. Barry Kaplan Receives Lifetime...
NewYorkPresbyterian Queens honored doctor for years of service instructing medical residentsFresh Meadows NY PRWEB June 21 2017 Queens Medical Associates Founder and President Dr. Barry Kaplan is the...
View ArticleSwissmedic accepts review of Takeda and TiGenixs file on Cx601
The Swiss Agency for Therapeutic Products Swissmedic has accepted a review of Takeda and TiGenixs file on investigational compound Cx601 for the treatment of complex perianal fistulas in patients with...
View ArticleSingle fungus amplifies Crohn's disease symptoms
Case Western Reserve University A microscopic fungus called Candida tropicalis triggered gut inflammation and exacerbated symptoms of Crohn's disease in a recent study conducted at Case Western Reserve...
View ArticleHigh fat diet reduces gut bacteria Crohn's disease symptoms
Case Western Reserve University Researchers at Case Western Reserve University School of Medicine have shown a high fat diet may lead to specific changes in gut bacteria that could fight harmful...
View ArticleCatabasis Announces Positive Phase 1 Data for CAT1004 Validating the SMART...
CAMBRIDGE Mass. Feb. 11 2013 PRNewswire &160;Catabasis Pharmaceuticals Inc. today announced that a threepart series of Phase 1 studies showed that CAT1004 a SMART Linker conjugate of...
View ArticleCrohns Disease Severity Amplified by Fungus
Inflammatory bowel disease IBD affects millions worldwide and can often lead to serious intestinal disorders if left unchecked. While there has been a wave of IBD drugs that have recently come to...
View ArticleLab Grown Human Colons Change Study of GI Disease
CINCINNATI June 22 2017 PRNewswireUSNewswire Scientists used human pluripotent stem cells to generate human embryonic colons in a laboratory that function much like natural human tissues when...
View ArticleStudy shows howÂhigh fatÂdiets can alter gut bacteria to combat harmful...
Researchers at Case Western Reserve University School of Medicine have shown a high fat diet may lead to specific changes in gut bacteria that could fight harmful inflammationa major discovery for...
View ArticleSoligenix Announces Formation of Oral Mucositis Medical Advisory Board
PRINCETON N.J. Feb. 4 2013 PRNewswire Soligenix Inc. OTCQB SNGX Soligenix or the Company a developmentstage biopharmaceutical company announced today the formation of a Medical Advisory Board MAB to...
View ArticleSoligenix Receives $521000 in NonDilutive Financing from New Jersey's...
PRINCETON N.J. Dec. 28 2012 PRNewswire &160;Soligenix Inc. OTCQB SNGX Soligenix or the Company a development stage biopharmaceutical company announced today that it has recently received...
View ArticleSamsung Bioepis' Imraldi Adalimumab Recommended for Approval by European...
The positive opinion from the European Medicines Agencys Committee for Medicinal Products for Human Use will now be referred to the European Commission which will review and decide on the grant of a...
View ArticleBiogens IMRALDIÂ an Adalimumab Biosimilar Candidate Referencing HumiraÂ...
If approved IMRALDI would be the third antiTNF biosimilar in Biogens portfolio in Europe helping to expand affordable therapy options and increase access for patients with chronic antiinflammatory...
View ArticleMedical News Today Plant fats alter gut bacteria to ease Crohn's symptoms
A diet high in coconut oil and other plantderived fats may alter gut bacteria diversity reducing gut inflammation for patients with Crohn's disease.
View ArticleTakeda prepping to take over EU production of stem cell therapy from 2021
Takeda says it is assessing manufacturing options ahead of potential European approval later this year of the Crohns disease stem cell therapy licensed from TiGenix.
View ArticleEMA recommends approval of Humira biosimilar Imraldi
The European Medicines Agency has recommended the approval of the Imraldi making it the third antiTNF biosimilar candidate to receive a positive opinion from the Committee for Medicinal Products for...
View ArticleTakeda et TiGenix annoncent que Swissmedic a accept la demande dvaluation...
TiGenix &8212; Tuesday June 20th 2017 at 500am UTC COMMUNIQU DE PRESSE Takeda et TiGenix annoncent que Swissmedic a accept la demande d&8217;valuation relative au Cx106 pour le traitement des...
View ArticleCrohn's disease CD Epidemiology Forecast To 2023 Updated 31052017 Prices from...
DelveInsight Crohn's disease CD Epidemiology Forecast To 2023 provides an overview of the epidemiology trends of Crohn's disease CD in seven major markets US France Germany Italy Spain UK and Japan. It...
View Article